Advanced nanocarriers for an antitumor peptide
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Dendrimers and Hyperbranched Polymers · RNA Interference and Gene Delivery · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (70)
Show source-provided references
1. Ainalem ML, Campbell RA, Khalid S, Gillams RJ, Rennie AR, Nylander T (2010) On the ability of PAMAM dendrimers and dendrimer/DNA aggregated to penetrate POPC model biomembranes. J Phys Chem B 114(21):7229–724410.1021/jp9119809 ↗
2. Al-Tahami K, Singh J (2007) Smart polymer based delivery systems for peptides and proteins. Recent Pat Drug Deliv Formul 1:65–7110.2174/187221107779814113 ↗
3. Amado E, Blume A, Kressler J (2009) Novel non-ionic block copolymers tailored for interaction with phospholipids. React Funct Polym 69:450–45610.1016/j.reactfunctpolym.2008.12.021 ↗
4. Annabi B, Bouzeghrane M, Currie JC, Hawkins R, Dulude H, Daigneault L, Ruiz M, Wisniewski J, Garde S, Rabbani SA, Panchal C, Wu JJ, Béliveau R (2005) APSP94-derived peptide PCK3145 inhibits MMP-9 secretion and triggers CD44 cell surface shedding: implication in tumor metastasis. Clin Exp Metastasis 22:429–43910.1007/s10585-005-2669-1 ↗
5. Annabi B, Bouzeghrane M, Currie JC, Dulude H, Daigneault L, Garde S, Rabbani SA, Panchal C, Wu JJ, Béliveau R (2006) Inhibition of MMP-9 secretion by anti-metastatic PSP-94derived peptide PCK3145 requires cell surface laminin receptor signaling. Anticancer Drugs 17:429–43810.1097/01.cad.0000203388.68034.06 ↗
6. Arnida Janát-Amsbury MM, Ray A, Peterson CM, Chandehari H (2011) Geometry and surface characteristics of gold nanoparticles influence their distribution and uptake by macrophages. Eur J Pharm Biopharm 77:417–42310.1016/j.ejpb.2010.11.010 ↗
7. Asthana A, Chauhan AS, Diwan PV, Jain NK (2005) Poly(amidoamine) (PAMAM) dendritic nanostructures for controlled site-specific delivery of acidic anti-inflammatory active ingredient. AAPS PharmSciTech 6(3):E536–E54210.1208/pt060367 ↗
8. Aulenta F, Hayes W, Rannard S (2003) Dendrimers a new class of nanoscopic containers and delivery devices. Eur Polym J 39:1741–177110.1016/S0014-3057(03)00100-9 ↗
9. Bangham AD, Standish MM, Watkins JC (1965) Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 13:238–25210.1016/S0022-2836(65)80093-6 ↗
10. Becker AL, Henzler K, Welsch N, Ballauff M, Borisov O (2012) Proteins and polyelectrolytes: a charged relationship. Curr Opin Colloid Interface Sci 17:90–9610.1016/j.cocis.2011.10.001 ↗
11. Bonicelli MG, Giasanti L, Ierino M, Mancini G (2011) Interaction of cationic liposomes with cell membrane models. J Colloid Interface Sci 355:1–810.1016/j.jcis.2010.12.005 ↗
12. Burchard W (1983) Static and dynamic light scattering from branched polymers and biopolymers. Adv Polym Sci 48:1–12410.1007/3-540-12030-0_1 ↗
13. Capriotti AL, Garacciolo G, Gavaliere C, Foglia P, Pozzi D, Samperi R, Laganá A (2012) Do plasma proteins distinguish between liposomes of varying charge density? J Proteomics 75:1924–193210.1016/j.jprot.2012.01.003 ↗
14. Chauhan AS, Diwan PV, Jain NK, Tomalia DA (2009) Unexpected in vivo anti-inflammatory activity observed for simple, surface functionalized poly(amidoamine) dendrimers. Biomacromolecules 10:1195–120210.1021/bm9000298 ↗
15. Cheng Y, Xu Z, Ma M, Xu T (2008) Dendrimers as drug carriers: applications in different routes of drug administration. J Pharm Sci 97:123–14310.1002/jps.21079 ↗
16. Choi YS, Cho TS, Kim JM, Han SW, Kim SK (2006) Amine terminated G-6 PAMAM dendrimer and its interaction with DNA probed by Hoeschst 33258. Biophys Chem 121(2):142–14910.1016/j.bpc.2006.01.005 ↗
17. Cloninger M (2002) Biological application of dendrimers. Curr Opin Chem Biol 6:742–74810.1016/S1367-5931(02)00400-3 ↗
18. Crommelin DJ, Florence AT (2013) Towards more effective advanced drug delivery systems. Int J Pharm 454:496–51110.1016/j.ijpharm.2013.02.020 ↗
19. D’ Emanuele A, Attwood D (2005) Dendrimer–drug interactions. Adv Drug Deliv Rev 57:2147–216210.1016/j.addr.2005.09.012 ↗
20. Delgado AV, Conzález-Caballero F, Hunter RJ, Koopal LK, Lyklema J (2007) Measurement and interpretation of electrokinetic phenomena. J Colloid Interface Sci 309:194–22410.1016/j.jcis.2006.12.075 ↗
21. DeMattei CR, Huang B, Tomalia DA (2004) Designed dendrimer syntheses by self-assembly of single-site, ssDNA functionalized dendrons. Nano Lett 4:771–77710.1021/nl034957m ↗
22. Demetzos C (2006) Dendrimers as drug carriers: a new approach to increase the potential of bioactive natural products. Nat Prod Commun (NPC) 7:593–600
23. Eichman J, Bielinska A, Kukowska-Latallo J, Donovan B, Baker J (2001) In: Frechet J, Tomalia D (eds) Dendrimers and other demdritic polymers. Wiley, Chisester, pp 441–46210.1002/0470845821.ch18 ↗
24. Esfand R, Tomalia DA (2001) Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications. Drug Discov Today 6:427–43610.1016/S1359-6446(01)01757-3 ↗
25. Gardikis K, Tsimplouli C, Dimas K, Micha-Screttas M, Demetzos C (2010) New chimeric advanced drug delivery nano system (chi-aDDnSs) as doxorubicin carriers. Int J Pharm 402:231–23710.1016/j.ijpharm.2010.10.007 ↗
26. Gardikis K, Fessas D, Signorelli M, Dimas K, Tsimplouli C, Ionov M, Demetzos C (2011) A new chimeric drug delivery nano system (chi-aDDnS) composed of PAMAM-G4 G 3.5 dendrimer and liposomes as doxorubicin’s carrier. In vitro pharmacological studies. J Nanosci Nanotechnol 5:3764–377210.1166/jnn.2011.3847 ↗
27. Gregoriadis G, Wills EJ, Swain CP, Tavill AS (1974) Drug-carrier potential of liposomes in cancer chemotherapy. Lancet 1:1313–131610.1016/S0140-6736(74)90682-5 ↗
28. Gupta U, Agashe HB, Asthana A, Jain NK (2006) Dendrimers: novel polymeric nanoarchitectures for solubility enhancement. Biomacromolecules 7:649–65810.1021/bm050802s ↗
29. Jin GW, Koo H, Nam K, Kim H, Lee S, Park JS, Lee Y (2011) PAMAM dendrimer with a 1,2-diaminoethane surface facilitates endosomal escape for enhances pDNA delivery. Polymer 52:339–34610.1016/j.polymer.2010.10.066 ↗
30. Haladjova E, Rangelov S, Tsvetanov CB, Pispas S (2012) DNA encapsulation via nanotemplates from cationic block copolymer micelles. Soft Matter 8:2884–288910.1039/c2sm07029d ↗
31. Hartig SM, Greene RR, DasGupta J, Carlesso G, Dikov MM, Prokop A, Danidson JM (2007) Multifunctional nanoparticulate polyelectrolyte complexes. Pharm Res 24:2353–236910.1007/s11095-007-9459-1 ↗
32. Heutault B, Saulnier P, Pech B, Proust JE, Benoit JP (2003) Physico-chemical stability of colloidal lipid particles. Biomaterials 24:4283–430010.1016/S0142-9612(03)00331-4 ↗
33. Hofheinz RD, Gnad-Vogt SU, Beyer U, Hochhaus A (2005) Liposomal encapsulated anti-cancer drugs. Anticancer Drugs 16:691–70710.1097/01.cad.0000167902.53039.5a ↗
34. Jevprasesphant R, Penny J, Attwood D, D’Emanuele A (2004) Transport of dendrimer nanocarriers through epithelial cells via the transcellular route. J Controlled Release 97:259–26710.1016/j.jconrel.2004.03.022 ↗
35. Kaditi E, Mountrichas G, Pispas S, Demetzos C (2012) Block copolymers for drug delivery nano systems (DDnSs). Curr Med Chem 19:5088–510010.2174/0929867311209025088 ↗
36. Kapoor M, Burgess DJ, Patil SD (2012) Physicochemical characterization techniques for lipid based delivery syatems for siRNA. Int J Pharm 427:35–5710.1016/j.ijpharm.2011.09.032 ↗
37. Karayianni M, Pispas S (2012) Complexation of stimuli-responsive star-like amphiphilic block polyelectrolyte micelles with lysozyme. Soft Matter 8:8758–876910.1039/c2sm26084k ↗
38. Karayianni M, Pispas S, Chryssikos GD, Gionis V, Giatrellis S, Nounesis G (2011) Complexation of lysozyme with poly(sodium (sulfamate-carboxylate)isoprene). Biomacromolecules 12:1697–170610.1021/bm200066t ↗
39. Law SL, Lo WY, Pai SH, The GW, Kou FY (1986) The adsorption of bovine serum albumin by liposomes. Int J Pharm 32:237–24110.1016/0378-5173(86)90184-5 ↗
40. Maingi V, Kumar MV, Maiti PK (2012) PAMAM dendrimer-drug interactions: effect of pH on the binding and release pattern. J Phys Chem B 116:4370–437610.1021/jp211515g ↗
41. Mantzaridis C, Mountrichas G, Pispas S (2009) Complexes between high charge density cationic polyelectrolytes and anionic single- and double-tail surfactants. J Phys Chem B 113:7064–707010.1021/jp8095874 ↗
42. Menjoge AR, Kannan RM, Tomalia DA (2010) Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications. Drug Discov Today 15:171–18510.1016/j.drudis.2010.01.009 ↗
43. Mountrichas G, Pispas S (2007) Novel double hydrophilic block copolymers based on poly(p-hydroxystyrene) derivatives and poly(ethylene oxide). J Polym Sci Part A 45:5790–579910.1002/pola.22329 ↗
44. Mountrichas G, Mantzaridis C, Pispas S (2006) Well-defined flexible polyelectrolytes with two cationic sites per monomeric unit. Macromol Rapid Comm 27:289–29410.1002/marc.200500699 ↗
45. Ohki S, Arnold K (2000) A mechanism for ion-induced lipid fusion. Colloids Surf B 18:83–9710.1016/S0927-7765(99)00131-9 ↗
46. Ohki S, Ohshima H (1999) Interaction and aggregation of lipid vesicles (DLVO theory versus modified DLVO theory). Colloids Surf B 14:27–4510.1016/S0927-7765(99)00022-3 ↗
47. Pippa N, Pispas S, Demetzos C (2012a) The delineation of the morphology of charged liposomal vectors via a fractal analysis in aqueous and biological media: physicochemical and self-assembly studies. Int J Pharm 437:264–27410.1016/j.ijpharm.2012.08.017 ↗
48. Pippa N, Pispas S, Demetzos C (2012b) The fractal hologram and elucidation of the structure of liposomal carriers in aqueous and biological media. Int J Pharm 430:65–7310.1016/j.ijpharm.2012.03.048 ↗
49. Pippa N, Kaditi E, Pispas S, Demetzos C (2013a) PEO-b-PCL/DPPC chimeric nanocarriers: self-assembly aspects in aqueous and biological media and drug incorporation. Soft Matter 9:4073–408210.1039/c3sm27447k ↗
50. Pippa N, Merkouraki M, Pispas S, Demetzos C (2013b) DPPC:MPOx chimeric advanced Drug Delivery nanosystems (chi-aDDnSs): physicochemical and structural characterization, stability and drug release studies. Int J Pharm 450:1–1010.1016/j.ijpharm.2013.03.052 ↗
51. Pippa N, Kaditi E, Pispas S, Demetzos C (2013c) DPPC/poly(2-methyl-2-oxazoline)-grad-poly(2-phenyl-2-oxazoline) chimeric nanostructures as potential drug nanocarriers. J Nanopart Res 15:168510.1007/s11051-013-1685-3 ↗
52. Pippa N, Psarommati F, Pispas S, Demetzos C (2013d) The shape/morphology balance: a study of stealth liposomes via fractal analysis and drug encapsulation. Pharm Res 30:2385–239510.1007/s11095-013-1082-8 ↗
53. Pispas S (2007) Complexes of lysozyme with sodium (sulfamate-carboxylate)isoprene/ethylene oxide double hydrophilic block copolymers. J Polym Sci Part A 45:509–52010.1002/pola.21871 ↗
54. Reis CP, Ribeiro AJ, Veiga F, Neufeld RJ, Damgé C (2008) Polyelectrolyte biomaterial interactions provide nanoparticulate carrier for oral insulin delivery. Drug Deliv 15:127–13910.1080/10717540801905165 ↗
55. Rowland M, Noe CR, Smith DA, Tucker GT, Crommelin DJ, Peck CC, Rocci ML Jr, Basançon L, Shah VP (2012) Impact of the pharmaceutical sciences on health care: a reflection over the past 50 years. J Pharm Sci 101:4075–409910.1002/jps.23295 ↗
56. Ruozi B, Forni F, Battini R, Vandelli MA (2003) Cationic liposomes for gene transfection. J Drug Target 11:407–41410.1080/10611860310001655600 ↗
57. Sabín J, Prieto G, Ruso JM, Messina PV, Salgado FJ, Nogueira M, Costas M, Sarmiento F (2009) Interactions between DMPC liposomes and the serum blood proteins HSA and IgG. J Phys Chem B 113:1655–166110.1021/jp804641e ↗
58. Sadekar S, Ghandehari H (2012) Transepithelial transport and toxicity of PAMAM denedrimers: implications for oral drug delivery. Adv Drug Deliv Rev 64(6):571–58810.1016/j.addr.2011.09.010 ↗
59. Shukeir N, Arakelian A, Chen G, Garde S, Ruiz M, Panchal C, Rabbani SA (2004) A synthetic 15mer peptide (PCK3145) derived from prostate secretory protein can reduce tumor growth, experimental skeletal metastases, and malignancy-associated hypercallcemia. Cancer Res 64:5370–537710.1158/0008-5472.CAN-04-0788 ↗
60. Slingerland M, Guchelaar HJ, Gelderblom H (2012) Liposomal drug formulations in cancer therapy: 15 years along the road. Drug Discov Today 17:160–16610.1016/j.drudis.2011.09.015 ↗
61. Stepanek M, Matejicek P, Prochazka K, Filippov SK, Angelov B, Slouf M, Mountrichas G, Pispas S (2011) Polyelectrolyte-surfactant complexes formed by poly-[3,5-bis(trimethylammoniummethyl)-4-hydroxystyrene iodide]-block-poly(ethylene oxide) and sodium dodecyl sulfate in aqueous solutions. Langmuir 27:5275–528110.1021/la200442s ↗
62. Svenson S, Tomalia DA (2005) Dendrimers in biomedical applications—reflections on the field. Adv Drug Deliv Rev 57(15):2106–212910.1016/j.addr.2005.09.018 ↗
63. Tomalia DA (2009) In quest of a systematic framework for unifying and defining nanoscience. J Nanopart Res 11:1251–131010.1007/s11051-009-9632-z ↗
64. Tomalia DA, Baker H, Dewald J, Hall M, Kallos G, Martin S, Roeck J, Ryder J, Smith P (1985) A new class of polymers: starburst-dendritic macromolecules. Polym J 17:117–13210.1295/polymj.17.117 ↗
65. Tomalia DA, Reyna LA, Svenson S (2007) Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging. Biochem Soc Trans 35:61–6710.1042/BST0350061 ↗
66. Torchilin VP (2004) Targeted polymeric micelles for delivery of poorly soluble drugs. Cell Mol Life Sci 61:2549–255910.1007/s00018-004-4153-5 ↗
67. Torchilin VP (2007) Micellar Nanocarriers: pharmaceutical perspectives. Pharm Res 21:1–15
68. Vallianatou T, Tsantili-Kakoulidou A (2013) In silico methods of ADME(T) prediction: a brief review. Pharmakeftiki 25(II):55–67
69. Varkouhi AK, Mountrichas G, Schiffelers RM, Lammers T, Storm G, Pispas S, Hennik WE (2012) Polyplexes based on cationic polymers with strong nucleic acid binding properties. Eur J Pharm Sci 45:459–46610.1016/j.ejps.2011.09.002 ↗
70. Wu SY, McMillan NAJ (2009) Lipidic systems for in vivo siRNA delivery. AAPS J 11:639–65210.1208/s12248-009-9140-1 ↗